P/F Bakkafrost (BKFKY) Q2 2026 Earnings Call Transcript

This is more of a quality-upgrade than a growth inflection. The market should care less about the headline volume mix and more about the fact that management is actively trading near-term output for lower biological risk in Scotland; that usually compresses downside tails and supports valuation once investors believe the asset base is de-risked. For a salmon name, that can matter more than a one-quarter harvest miss because it reduces the odds of a sudden earnings reset.

The second-order winner is the balance sheet and cash conversion profile: preserving internal fishmeal inventory and feeding self-sufficiency lowers input volatility for the next two quarters, which should make forward EBITDA less dependent on spot marine-ingredient markets. That also creates spillover pressure on external fishmeal/oil suppliers and feed competitors that rely on purchased raw material rather than captive inventory. If salmon pricing stays firm, BKFKF can show better margin durability than peers even with a softer Scottish contribution.

The contrarian risk is that investors may be too quick to extrapolate the Faroes strength while underestimating how long Scotland remains a drag on reported growth. If the large-smolt ramp slips again, the equity becomes a cash-yield story rather than a re-rating story, and the market will punish any sign that 2027 biomass growth is being pushed out. Falsifiers are simple: a lack of Scottish volume recovery over the next 1-2 quarters, or evidence that feed cost savings unwind once inventory is consumed after Q2 next year.